Expand chart
Data: FactSet; Chart: Axios Visuals

President Trump's use of two prominent treatments for COVID-19 has sparked interest in the two companies behind the drugs remdesivir and REGN-COV2.

The state of play: Shares of Regeneron Pharmaceuticals, which makes REGN-COV2, and Gilead Sciences, maker of remdesivir, each rallied on Monday, but they have delivered very different returns for investors so far this year.

Disclaimer: Trump's recovery so far is not an endorsement for either product, as the president likely received a host of other treatments and had access to world-class facilities.

  • Randomized clinical trials on the drugs are ongoing.

Go deeper

Trump calls getting coronavirus "a blessing in disguise"

President Trump said in a new video on Wednesday evening that contracting the coronavirus was "a blessing in disguise" and claimed — without scientific evidence — that the antibody cocktail from Regeneron Pharmaceuticals he was treated with is a "cure."

Driving the news: The president said he is seeking emergency use authorization for the antibody cocktail, which he received last week while experiencing "mild" symptoms. He claimed that it was his suggestion to doctors that he be treated with the therapeutic, which Regeneron says has only been given to fewer than 10 people outside of clinical trials.

Pence to continue traveling despite aides testing positive for COVID-19

Marc Short with Pence in March. Photo: Drew Angerer/Getty Images

Marc Short, Vice President Mike Pence’s chief of staff, tested positive for the coronavirus Saturday and is quarantining, according to a White House statement.

Why it matters: Short is Pence's closest aide, and was one of the most powerful forces on the White House coronavirus task force. Pence and second lady Karen Pence tested negative for the virus on Sunday morning, according to the vice president's office.

AOC: "Extremely important" that Biden offer Bernie Sanders a Cabinet position

Rep. Alexandria Ocasio-Cortez (D-N.Y.) said on CNN's "State of the Union" Sunday that she believes it's "extremely important" that Joe Biden offer Sen. Bernie Sanders and other progressive leaders Cabinet positions if he's elected president.

The big picture: Ocasio-Cortez was pressed repeatedly on policy differences between her and the more moderate Biden, including her opposition to fracking and support for Medicare for All. She responded that it would be a "privilege" and a "luxury" to be able to lobby a Biden administration on progressive issues, insisting that the focus right now should be on winning the White House.